V2R structure and diabetes insipidus

被引:12
作者
Birnbaumer, M
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Physiol, Inst Mol Biol, Los Angeles, CA 90095 USA
关键词
ADH (antidiuretic hormone); diabetes insipidus; V2; receptor;
D O I
10.1080/10606820212134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
For most audiences, the term "diabetes" conjures thoughts of high levels of blood glucose and of the symptoms that characterize diabetes mellitus. In the last few years, a spirited campaign spearheaded by the families of affected individuals has made progress in educating nonprofessional and medical communities about diabetes insipidus (DI), the other disease characterized by polyuria (i.e., diabetes). Much work lies ahead to find better treatments for this affliction, but the progress in molecular biology over the last years made possible the identification of the genetic defects underlying the inherited forms of the disease. Numerous cases of adult-onset DI are triggered by toxic damage to the kidneys that impairs the concentrating capacity of the nephrons by a nonspecific mechanism. In these pages I shall deal mostly with the inherited forms of the disease. Diabetes insipidus is characterized by the inability of the kidneys of affected individuals to produce concentrated urine (Morello and Bichet 2001). The elimination of large volumes of diluted urine (polyuria) and excessive thirst (polydipsia) are the chief symptoms of the disease. Although this condition and the hints that it was a hereditary disease were described at the end of the 19th century, it took almost 100 years to gain molecular knowledge about its etiology. A brief review of the important role played by vasopressin in the maintenance of body fluids will help the reader understand the severity of this disease.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 43 条
[1]   EPINEPHRINE AND DDAVP ADMINISTRATION IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS - EVIDENCE FOR A PRE-CYCLIC AMP V2-RECEPTOR DEFECTIVE MECHANISM [J].
BICHET, DG ;
RAZI, M ;
ARTHUS, MF ;
LONERGAN, M ;
TITTLEY, P ;
SMILEY, RK ;
ROCK, G ;
HIRSCH, DJ .
KIDNEY INTERNATIONAL, 1989, 36 (05) :859-866
[2]   X-LINKED NEPHROGENIC DIABETES-INSIPIDUS MUTATIONS IN NORTH-AMERICA AND THE HOPEWELL HYPOTHESIS [J].
BICHET, DG ;
ARTHUS, MF ;
LONERGAN, M ;
HENDY, GN ;
PARADIS, AJ ;
FUJIWARA, TM ;
MORGAN, K ;
GREGORY, MC ;
ROSENTHAL, W ;
DIDWANIA, A ;
ANTARAMIAN, A ;
BIRNBAUMER, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1262-1268
[3]  
BICHET DG, 1994, AM J HUM GENET, V55, P278
[4]   AN EXTRACELLULAR CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS MUTATION OF THE VASOPRESSIN RECEPTOR REDUCES CELL-SURFACE EXPRESSION, AFFINITY FOR LIGAND, AND COUPLING TO THE G(S)/ADENYLYL CYCLASE SYSTEM [J].
BIRNBAUMER, M ;
GILBERT, S ;
ROSENTHAL, W .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (07) :886-894
[5]   MOLECULAR-CLONING OF THE RECEPTOR FOR HUMAN ANTIDIURETIC-HORMONE [J].
BIRNBAUMER, M ;
SEIBOLD, A ;
GILBERT, S ;
ISHIDO, M ;
BARBERIS, C ;
ANTARAMIAN, A ;
BRABET, P ;
ROSENTHAL, W .
NATURE, 1992, 357 (6376) :333-335
[6]   The V2 vasopressin receptor mutations and fluid homeostasis [J].
Birnbaumer, M .
CARDIOVASCULAR RESEARCH, 2001, 51 (03) :409-415
[7]   Vasopressin receptor mutations and nephrogenic diabetes insipidus [J].
Birnbaumer, R .
ARCHIVES OF MEDICAL RESEARCH, 1999, 30 (06) :465-474
[8]   NEPHROGENIC DIABETES INSIPIDUS IN NORTH AMERICA - HOPEWELL HYPOTHESIS [J].
BODE, HH ;
CRAWFORD, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (14) :750-&
[9]   Osmoreceptors in the central nervous system [J].
Bourque, CW ;
Oliet, SHR .
ANNUAL REVIEW OF PHYSIOLOGY, 1997, 59 :601-619
[10]   REQUIREMENT OF HUMAN RENAL WATER CHANNEL AQUAPORIN-2 FOR VASOPRESSIN-DEPENDENT CONCENTRATION OF URINE [J].
DEEN, PMT ;
VERDIJK, MAJ ;
KNOERS, NVAM ;
WIERINGA, B ;
MONNENS, LAH ;
VANOS, CH ;
VANOOST, BA .
SCIENCE, 1994, 264 (5155) :92-95